NCT05977205View on ClinicalTrials.gov

COVID-19 Glycemic Control Study

CompletedOBSERVATIONAL
Enrollment

492

Participants

Timeline

Start Date

May 2, 2020

Primary Completion Date

July 10, 2020

Study Completion Date

July 10, 2020

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
OTHER

No interventions, observational study

Not applicable, no interventions, observational study

Trial Locations (1)

2333 ZA

Leiden University Medical Center, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER

NCT05977205 - COVID-19 Glycemic Control Study | Biotech Hunter | Biotech Hunter